25. 進行性多巣性白質脳症 Disease details / Clinical trials / Drug dev / DR info

111jc101
   Biogen Idec Ltd
      2009   -   EUCTR2008-001314-24-GB   France;Italy;Spain;United Kingdom
      2008   Phase 2   EUCTR2008-001314-24-FR   France;Italy;Spain;United Kingdom
      2008   Phase 2   EUCTR2008-001314-24-ES   France;Italy;Spain;United Kingdom
89 ZR-DF-crefmirlimab
   National Institute of Neurological Disorders and Stroke (NINDS)
      2023   Phase 1   NCT05849467   United States
Brain MRI
   University Hospital, Toulouse
      2021   -   NCT04453917   France
CE-VST01-JC
   Cellevolve Bio Inc
      2023   Phase 2   NCT05541549   -
Cidofovir
   National Institute of Allergy and Infectious Diseases (NIAID)
      1999   -   NCT00000945   United States
Collection OF blood and urine
   University Hospital, Toulouse
      2021   -   NCT04453917   France
CYT107
   CYTHERIS
      2012   -   EUCTR2012-000725-41-IT   Italy;Spain;Switzerland;United Kingdom;United States
   Cytheris S.A.
      2013   -   EUCTR2012-000725-41-GB   European Union;Italy;Spain;Switzerland;United Kingdom;United States
      2012   -   EUCTR2012-000725-41-ES   European Union;Spain;Switzerland;United Kingdom;United States
Cytarabine
   National Institute of Allergy and Infectious Diseases (NIAID)
      1998   Phase 2   NCT00001048   United States
Didanosine
   Bristol-Myers Squibb
      1997   -   NCT00002274   United States
   National Institute of Allergy and Infectious Diseases (NIAID)
      1998   Phase 2   NCT00001048   United States
Enfuvirtide
   French National Agency for Research on AIDS and Viral Hepatitis
      2005   Phase 2   NCT00120367   France
Filgrastim
   National Institute of Allergy and Infectious Diseases (NIAID)
      1998   Phase 2   NCT00001048   United States
Interferon ALFA-2B
   University of Miami
      1997   -   NCT00002270   United States
Lariam
   BIOGEN IDEC LTD
      2009   -   EUCTR2008-001314-24-IT   France;Italy;Spain;United Kingdom
   Biogen Idec Ltd
      2009   -   EUCTR2008-001314-24-GB   France;Italy;Spain;United Kingdom
      2008   Phase 2   EUCTR2008-001314-24-FR   France;Italy;Spain;United Kingdom
      2008   Phase 2   EUCTR2008-001314-24-ES   France;Italy;Spain;United Kingdom
Mefloquine
   BIOGEN IDEC LTD
      2009   -   EUCTR2008-001314-24-IT   France;Italy;Spain;United Kingdom
   Biogen
      2009   Phase 1/Phase 2   NCT00746941   Australia;Brazil;France;Germany;Italy;Puerto Rico;Spain;United Kingdom;United States
   Biogen Idec Ltd
      2009   -   EUCTR2008-001314-24-GB   France;Italy;Spain;United Kingdom
      2008   Phase 2   EUCTR2008-001314-24-FR   France;Italy;Spain;United Kingdom
      2008   Phase 2   EUCTR2008-001314-24-ES   France;Italy;Spain;United Kingdom
   Department of Neurology, Shimane University Hospital
      2016   -   JPRN-UMIN000022151   Japan
   Nagoya City University
      2016   -   JPRN-UMIN000023752   Japan
Methylprednisolone
   Biogen
      2010   Phase 4   NCT01211665   Germany;United States
   Biogen Idec
      2010   -   EUCTR2010-020369-26-DE   Germany
Natalizumab
   Biogen
      2019   -   NCT05236777   Czechia
Neurological evaluation
   University Hospital, Toulouse
      2021   -   NCT04453917   France
NT-I7
   National Institute of Neurological Disorders and Stroke (NINDS)
      2021   Early Phase 1   NCT04781309   United States
Pembrolizumab
   First Affiliated Hospital of Zhejiang University
      2019   Phase 2   NCT04091932   China
Pembrolizumab, 25 MG/ML solution FOR intravenous (IV) injection
   Assistance Publique - Hôpitaux de Paris
      2024   Phase 2/Phase 3   NCT06276504   France
Prednisolone
   Biogen
      2010   Phase 4   NCT01211665   Germany;United States
   Biogen Idec
      2010   -   EUCTR2010-020369-26-DE   Germany
Probenecid
   National Institute of Allergy and Infectious Diseases (NIAID)
      1999   -   NCT00000945   United States
Pyvst
   National Institute of Neurological Disorders and Stroke (NINDS)
      2016   Early Phase 1   NCT02694783   United States
Recombinant human interleukin-7
   CYTHERIS
      2012   -   EUCTR2012-000725-41-IT   Italy;Spain;Switzerland;United Kingdom;United States
   Cytheris S.A.
      2013   -   EUCTR2012-000725-41-GB   European Union;Italy;Spain;Switzerland;United Kingdom;United States
      2012   -   EUCTR2012-000725-41-ES   European Union;Spain;Switzerland;United Kingdom;United States
Spinal TAP
   University Hospital, Toulouse
      2021   -   NCT04453917   France
Tenofovir-emtricitabine
   French National Agency for Research on AIDS and Viral Hepatitis
      2005   Phase 2   NCT00120367   France
Teriflunomide
   Providence Health & Services
      2013   Phase 4   NCT01970410   United States
Topotecan
   SmithKline Beecham
      1996   Phase 2   NCT00002395   United States
Tysabri
   Biogen
      2017   -   NCT03399981   United States
Zalcitabine
   National Institute of Allergy and Infectious Diseases (NIAID)
      1998   Phase 2   NCT00001048   United States
Zidovudine
   National Institute of Allergy and Infectious Diseases (NIAID)
      1998   Phase 2   NCT00001048   United States
   University of Miami
      1997   -   NCT00002270   United States